Advances in clinical NK cell studies: Donor selection, manufacturing and quality control Jul 20, 2023 | Uncategorized
The generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic Apr 25, 2023 | Lynch Syndrome, Uncategorized
An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression. Feb 12, 2015 | Uncategorized
Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer. Feb 12, 2015 | Uncategorized
